Atossa Therapeutics Reports Third Quarter Financial Results
Atossa Therapeutics (NASDAQ: ATOS) has released its financial results for the third quarter. The company reported a net loss of $0.56 per share during this period. In addition to the earnings report, the company noted that it generated $0.2 million in interest income during the quarter. These figures reflect the current fiscal standing of the biotechnology firm as it continues its operational activities.
Tickers: $ATOS
Topics: earnings interest income net loss